Cargando…
Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab
Vernal keratoconjunctivitis (VKC) is a severe ocular allergic disease characterized by chronic inflammation of the cornea and conjunctiva that may lead to loss of visual acuity and blindness. The disease occurs primarily in children and is more common in geographical regions characterized by warm te...
Autores principales: | Doan, Serge, Papadopoulos, Nikolaos G., Lee, Jason K., Leonardi, Salvatore, Manti, Sara, Lau, Susanne, Rondon, Carmen, Sharma, Vibha, Pleyer, Uwe, Jaumont, Xavier, Lazarewicz, Slawomir B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300397/ https://www.ncbi.nlm.nih.gov/pubmed/37389200 http://dx.doi.org/10.1016/j.waojou.2023.100788 |
Ejemplares similares
-
Clinical efficacy and safety of omalizumab in conventional treatment‐resistant vernal keratoconjunctivitis: Our experience and literature review
por: Manti, Sara, et al.
Publicado: (2021) -
Omalizumab in Severe Refractory Vernal Keratoconjunctivitis in Children: Case Series and Review of the Literature
por: Doan, Serge, et al.
Publicado: (2016) -
Management of Vernal Keratoconjunctivitis
por: Leonardi, Andrea
Publicado: (2013) -
Vernal keratoconjunctivitis
por: Addis, Hampton, et al.
Publicado: (2018) -
Vitiligo in association with vernal keratoconjunctivitis
por: Kumar, Sunil, et al.
Publicado: (2016)